Full View

Impact of sacubitril/valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction: the PARADISE-MI echocardiographic substudy

AM Shah, B Claggett, N Prasad, G Li, M Volquez… - Circulation, 2022 - Am Heart Assoc
Background: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …
被引用次数：33 相关文章

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

AM Shah, B Claggett, N Prasad, G Li, M Volquez… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

Impact of sacubitril/valsartan compared to ramipril on cardiac structure and function following acute myocardial infarction: The PARADISE-MI echocardiographic sub …

AM Shah, B Claggett, N Prasad, G Li, M Volquez… - Circulation, 2022 - eprints.gla.ac.uk
BACKGROUND: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

AM Shah, B Claggett, N Prasad, G Li, M Volquez… - …, 2022 - research.regionh.dk
BACKGROUND: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

AM Shah, B Claggett, N Prasad, G Li, M Volquez… - Circulation, 2022 - europepmc.org
Background Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

AM Shah, B Claggett, N Prasad, G Li, M Volquez… - …, 2022 - ingentaconnect.com
Background: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

AM Shah, B Claggett, N Prasad, G Li… - Circulation, 2022 - Am Heart Assoc
BACKGROUND: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

A SHAH, B CLAGGETT, N PRASAD, G LI… - …, 2022 - observatorio.fm.usp.br
BACKGROUND: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …

[引用][C] Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI …

A Shah, B Claggett, N Prasad, G Li, M Volquez… - Circulation, 2022 - repositorio.usp.br
ReP USP - Detalhe do registro: Impact of Sacubitril/Valsartan Compared With Ramipril on
Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI …

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic …

A Shah, B Claggett, N Prasad, G Li, M Volquez… - 2022 - documentserver.uhasselt.be
BACKGROUND: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …